[Psychopharmological research with EMD 16-923 in patients with different degrees of anxiety].
Sixty patients, ages 15 to 59, mostly neurotics, were used to study the effect of mepiprazol on the anxiety syndrome. The drug was compared to oxacepam. The results with mepiprazol were considered acceptable with no important collateral effects.
D000293:Adolescent; D000328:Adult; D001007:Anxiety / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010076:Oxazepam / Q000627:therapeutic use*; D010879:Piperazines / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use*
D010879:Piperazines; D011720:Pyrazoles; D010076:Oxazepam
Investigación psicofarmacológica con el EMD 16-923 en pacientes con diferentes grados de ansiedad.